A 28-kDa Splice Variant of NADPH Oxidase-4 Is Nuclear-Localized and Involved in Redox Signaling in Vascular Cells
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Objective—: Reactive oxygen species–generating nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase proteins (Noxs) are involved in cell differentiation, migration, and apoptosis. Nox4 is unique among Noxs in being constitutively active, and its subcellular localization may therefore be particularly important. In this study, we identified and characterized a novel nuclear-localized 28-kDa splice variant of Nox4 in vascular cells. Approach and Results—: Nox4 immunoreactivity was noted in the nucleus and nucleolus of vascular smooth muscle cells and multiple other cell types by confocal microscopy. Cell fractionation, sequence analyses, and siRNA studies indicated that the nuclear-localized Nox4 is a 28-kDa splice variant, Nox4D, which lacks putative transmembrane domains. Nox4D overexpression resulted in significant NADPH-dependent reactive oxygen species production as detected by several different methods and caused increased phosphorylation of extracellular-signal-regulated kinase1/2 and the nuclear transcription factor Elk-1. Overexpression of Nox4D could also induce DNA damage as assessed by γ-H2AX phosphorylation. These effects were inhibited by a single amino acid substitution in the Nox4D NADPH-binding region. Conclusions—: Nox4D is a nuclear-localized and functionally active splice variant of Nox4 that may have important pathophysiologic effects through modulation of nuclear signaling and DNA damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
γH2AX: a sensitive molecular marker of DNA damage and repair
Mah, L.-J., El-Osta, A., & Karagiannis, T. C. (2010) · Leukemia · doi:10.1038/leu.2010.6 · Cited by 1,557
Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839 · cited 1×
“For example, Nox1, but not Nox4, mediates angiotensin II–induced VSMC hypertrophy.(4,5) Endothelial cell Nox4 was found to have vasodilator effects in contrast to Nox2 expressed in the same cell type.”
BackgroundFunctional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases
Martyn, K. D., Frederick, L. M., von Loehneysen, K., Dinauer, M. C., & Knaus, U. G. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.023 · Cited by 783
NADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630
Self-citationNOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation
Serrander, L., Cartier, L., Bedard, K., Banfi, B., Lardy, B., Plastre, O., Sienkiewicz, A., Fórró, L., Schlegel, W., & Krause, K.-H. (2007) · Biochemical Journal · doi:10.1042/bj20061903 · Cited by 627
Distinct Subcellular Localizations of Nox1 and Nox4 in Vascular Smooth Muscle Cells
Hilenski, L. L., Clempus, R. E., Quinn, M. T., Lambeth, J. D., & Griendling, K. K. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000112024.13727.2c · Cited by 573 · cited 2×
“For example, Nox1, but not Nox4, mediates angiotensin II–induced VSMC hypertrophy.(4,5) Endothelial cell Nox4 was found to have vasodilator effects in contrast to Nox2 expressed in the same cell type.”
BackgroundAmbasta, R. K., Kumar, P., Griendling, K. K., Schmidt, H. H. H. W., Busse, R., & Brandes, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406486200 · Cited by 541
Ago, T., Kuroda, J., Pain, J., Fu, C., Li, H., & Sadoshima, J. (2010) · Circulation Research · doi:10.1161/circresaha.109.213116 · Cited by 506 · cited 2×
“We generated a Nox4D mutant with a single amino acid substitution in the NADPH-binding domain (proline 130 to histidine, Figure 10A) that would be expected to impair its activity based on previous studies with Nox4 and Nox2.(27,28) VSMCs were transfected with wild-type or mutant Nox4D (Nox4DM) and protein expression c…”
MethodKleinschnitz, C., Grund, H., Wingler, K., Armitage, M. E., Jones, E., Mittal, M., Barit, D., Schwarz, T., Geis, C., Kraft, P., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000479 · Cited by 447
Self-citationThe superoxide‐producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells
Kuroda, J., Nakagawa, K., Yamasaki, T., Nakamura, K., Takeya, R., Kuribayashi, F., Imajoh‐Ohmi, S., Igarashi, K., Shibata, Y., Sueishi, K., et al. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00907.x · Cited by 275 · cited 1×
“However, other subcellular locations have also been reported, including the nuclear envelope,(30) mitochondria,(17,31) and the intranuclear region.(19,32) A possible intranuclear localization of Nox4 is intriguing because it is not immediately obvious how a protein with 6 putative transmembrane domains would localize…”
Background
Cited by
Endoplasmic Reticulum Stress and Associated ROS
Zeeshan, H., Lee, G., Kim, H.-R., & Chae, H.-J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030327 · Cited by 941
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521
NADPH Oxidases in Vascular Pathology
Konior, A., Schramm, A., Czesnikiewicz-Guzik, M., & Guzik, T. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5607 · Cited by 452
Myofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation
Gibb, A. A., Lazaropoulos, M. P., & Elrod, J. W. (2020) · Circulation Research · doi:10.1161/circresaha.120.316958 · Cited by 434
ROS signaling and ER stress in cardiovascular disease
Ochoa, C. D., Wu, R. F., & Terada, L. S. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.03.002 · Cited by 325
Endothelial NADPH oxidases: which NOX to target in vascular disease?
Drummond, G. R., & Sobey, C. G. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.06.012 · Cited by 315
Molecular mechanisms underlying chronic inflammation-associated cancers
Wu, Y., Antony, S., Meitzler, J. L., & Doroshow, J. H. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.08.014 · Cited by 308
Montezano, A. C., & Touyz, R. M. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5302 · Cited by 270
Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases
Taleb, A., Ahmad, K. A., Ihsan, A. U., Qu, J., Lin, N., Hezam, K., Koju, N., Hui, L., & Qilong, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.140 · Cited by 215
Pharmacological characterization of the seven human NOX isoforms and their inhibitors
Augsburger, F., Filippova, A., Rasti, D., Seredenina, T., Lam, M., Maghzal, G., Mahiout, Z., Jansen-Dürr, P., Knaus, U. G., Doroshow, J., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101272 · Cited by 189
“A NOX4 splice variant of 28 kDa has been described [24].”
BackgroundNox NADPH Oxidases and the Endoplasmic Reticulum
Laurindo, F. R. M., Araujo, T. L. S., & Abrahão, T. B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5605 · Cited by 185
“However, the demonstration of cellular ROS generation for short alternatively spliced Nox4 isoforms lacking the transmembrane domain, such as Nox4D (56), which has recently been shown to display nuclear location (6), is consistent with such possibility.”
ROS signaling and redox biology in endothelial cells
Panieri, E., & Santoro, M. M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1928-9 · Cited by 168
“Importantly, ROS production from NADPH oxidases can occur either in the extracellular space or inside the cellular milieu, depending on the biological membrane wherein the enzyme is located, ranging from plasma membrane, endosomes, endoplasmic reticulum, nucleus, caveolae and mitochondria [77, 78].”
BackgroundFrazziano, G., Al Ghouleh, I., Baust, J., Shiva, S., Champion, H. C., & Pagano, P. J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00977.2012 · Cited by 51
Alternative Splicing of NOX4 in the Failing Human Heart
Varga, Z. V., Pipicz, M., Baán, J. A., Baranyai, T., Koncsos, G., Leszek, P., Kuśmierczyk, M., Sánchez-Cabo, F., García-Pavía, P., Brenner, G. J., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00935 · Cited by 43
“To date NOX4 transcripts variants have been reported only in cell lines, including alveolar epithelial cells (Goyal et al., 2005), vascular smooth muscle cells, endothelial cells, fibroblasts, and cardiomyocytes (Anilkumar et al., 2013).”
BackgroundMethod
Metadata
- Authors
- Anilkumar, N., Jose, G. S., Sawyer, I., Santos, C. X. C., Sand, C., Brewer, A. C., Warren, D., & Shah, A. M.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2013-04
- Volume
- 33
- Issue
- 4
- Pages
- e104-12
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2087878853
- Cited by
- 84
- References
- 12
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.